4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell

Affiliations

• 1 Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
• 2 Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
• 3 Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea.
• 4 Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, 25601, Republic of Korea.
• 5 Biomedicine Production Branch, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
• 6 Anticancer Resistance Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
• 7 Eutilex Co., Ltd., Geumcheon-gu, Seoul, 08594, Republic of Korea.
• 8 Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA, 70112, USA.
• 9 Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea. kitaek@yuhs.ac.
• 10 Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea. magetin@gmail.com.
• 11 Innobationbio Co., Ltd., Mapo-gu, Seoul, 03929, Republic of Korea. magetin@gmail.com.
• # Contributed equally.